naproxen has been researched along with gw406381x in 2 studies
Studies (naproxen) | Trials (naproxen) | Recent Studies (post-2010) (naproxen) | Studies (gw406381x) | Trials (gw406381x) | Recent Studies (post-2010) (gw406381x) |
---|---|---|---|---|---|
4,551 | 1,057 | 1,429 | 15 | 4 | 7 |
Protein | Taxonomy | naproxen (IC50) | gw406381x (IC50) |
---|---|---|---|
Prostaglandin G/H synthase 2 | Homo sapiens (human) | 0.003 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aurora, SK; Dixon, RM; Gold, M; Jimenez, TB; Wentz, AL | 1 |
Blum, D; Lomax, M; Quessy, S; Varner, J | 1 |
2 trial(s) available for naproxen and gw406381x
Article | Year |
---|---|
A double-blind, randomized, placebo-controlled, single-dose study of the cyclooxygenase-2 inhibitor, GW406381, as a treatment for acute migraine.
Topics: Adolescent; Adult; Aged; Cyclooxygenase 2 Inhibitors; Double-Blind Method; Drug Evaluation; Female; Humans; Hydrocarbons, Aromatic; Male; Middle Aged; Migraine Disorders; Naproxen; Nitrogen; Pain Measurement; Pyrazoles; Pyridazines; Statistics, Nonparametric; Time Factors | 2008 |
A randomized, controlled, dose-ranging study investigating single doses of GW406381, naproxen sodium, or placebo in patients with acute pain after third molar tooth extraction.
Topics: Adolescent; Adult; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Double-Blind Method; Enzyme Inhibitors; Female; Humans; Male; Molar, Third; Naproxen; Pain; Pain Measurement; Pyrazoles; Pyridazines; Retrospective Studies; Time Factors; Tooth Extraction; Treatment Outcome; Young Adult | 2009 |